Morgan Stanley Reduces PT on Salesforce (CRM) Stock

Core Insights - Salesforce, Inc. (NYSE:CRM) is recognized as a top AI and technology stock by hedge funds, with Morgan Stanley adjusting its price target to $398 from $405 while maintaining an "Overweight" rating following strong earnings [1][2]. Financial Performance - For Q3 FY 2025, Salesforce reported revenue of $10.3 billion, marking a 9% year-over-year increase and an 8% increase in constant currency, driven by growth in subscription and support revenues [2]. - The company's net income for Q3 FY 2025 was $2,086 million, up from $1,527 million in Q3 FY 2024, with key products like Agentforce and Data 360 contributing to this growth [3]. - Salesforce raised its FY 2026 revenue guidance to between $41.45 billion and $41.55 billion, with a strong cRPO of $29.4 billion, reflecting an 11% year-over-year increase, indicating a robust future revenue pipeline [3]. Market Position - Salesforce specializes in customer relationship management technology, connecting companies with their customers, and is considered a significant player in the AI and technology sectors [4].